Improvement of cardiac performance by intravenous infusion of l-arginine in patients with moderate congestive heart failure
Bella Koifman, Gad Keren, Tamara Chernichowsky(Tel Aviv University), Adrian Iaina(Tel Aviv Sourasky Medical Center), Shlomo Laniado, Miriam Blum, Ariel Finkelstein, Yoram Wollman(Tel Aviv Sourasky Medical Center), Natalie Bogomolny(Tel Aviv University), Gary Peer(Tel Aviv Sourasky Medical Center), Jack Scherez(Tel Aviv University)
Cited by 75
Related Papers
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
|The Lancet|2000|1k
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|729
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|645
Randomised crossover trial of naltrexone in uraemic pruritus
|The Lancet|1996|298